| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 5 |
| 1 | ONDANSETRON | 4 |
| 2 | ONDANSETRON HYDROCHLORIDE | 4 |
| 3 | APREMILAST | 3 |
| 4 | DALFAMPRIDINE | 3 |
| 5 | METFORMIN | 3 |
| 6 | OMEPRAZOLE | 3 |
| 7 | OMEPRAZOLE MAGNESIUM | 3 |
| 8 | DOCUSATE SODIUM | 2 |
| 9 | DOCUSATE SODIUM 100MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CUPRIC CHLORIDE | 1 | 0.0013 |
| 1 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 1 | 0.0009 |
| 2 | MIGLUSTAT | 1 | 0.0009 |
| 3 | BRODALUMAB | 1 | 0.0005 |
| 4 | PRUCALOPRIDE | 1 | 0.0004 |
| 5 | ARTIFICIAL TEARS | 1 | 0.0004 |
| 6 | POLYVINYL ALCOHOL, POVIDONE | 1 | 0.0004 |
| 7 | TEPROTUMUMAB | 2 | 0.0003 |
| 8 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 9 | ROPINIROLE HYDROCHLORIDE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 2 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 3 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 5 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 7 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 2 | 0.0001 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |